Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc is set to transform the country’s pharmaceutical manufacturing industry with the construction of its new World Health Organization (WHO)-standard Biotech Plant, located in Sango Ota area of Ogun State.
The company’s Managing Director, Dr Fidelis Ayebae made this known recently.
“With the new plant in place, Fidson Healthcare Plc will accomplish a world-class pharmaceutical manufacturing capacity, which will compete healthily with its foreign counterparts, thereby placing the country’s healthcare manufacturing sector on a global pedestal,” he said.
He further stated that presently, the company is almost exhausting its manufacturing capacity due to the volume of demands for its products by Nigerians, both at the Institutional and individual level.
“Therefore, it is imperative that a more massive manufacturing plant than the existing one is put in place to take care of the rapidly growing demand of the market.”
Dr Ayebae also emphasised that when completed, the plant will be used for manufacturing large scale pharmaceutical products that will take care of the healthcare needs of Nigerians, thereby further strengthens the company’s leadership position in the Nigeria pharmaceutical industry and also place Fidson on the global pharmaceutical platform.
The new Biotech plant construction is one of the ways Fidson Healthcare is demonstrating its commitment to the well-being of Nigerians and also fulfilling its corporate brand promise of providing excellent quality world-class healthcare solutions.
Comments